product Image
DiaPlexQ™ MTC/NTM Detection Kit (Tuberculosis)
Model Name
-
Series
Molecular Diagnostic (Pathogen Detection)
Data
-
Manufacturer information
provider logo
SOLGENT

DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus

Problem with product info?
Update request
Manufacturer
SOLGENT
Brand
-
SKU
125208
Product Name
DiaPlexQ™ MTC/NTM Detection Kit (Tuberculosis)
Model Name
-
Size
-
Weight
-
Product Details

DiaPlexQ™ MTC/NTM Detection Kit

Real-Time PCR based assay system for simultaneous detection of MTC and NTM complex

CE-IVD


M y cobacterium tuberculosis (MTB) is a pathogenic bacteria species and the causative agent in most cases of tuberculosis. Along with MTB, 5 other species, which we call MTC are regarded as common infectious agents causing tuberculosis. That is why it is necessary to detect MTC, along with MTB. Although NTM is a group of non-tuberculosis related mycobacteria, it usually causes lung infections that mimic tuberculosis resulting in a potential misdiagnosis. Thus, the identification of a single infection or co-infection of MTC and NTM is required for appropriate treatment.




Specification


DiaPlexQ™ MTC/NTM Detection KitDiaPlexQ™ MTC/NTM Detection Kit
ver 3.0
DiaPlexQ™ MTC/NTM Detection Kit
ver 4.0
Detection targetMTC (2 species): IS6110
NTM (13 species): 16S rRNA
MTC (2 species): IS6110, MPB64
NTM (15 species): 16S rRNA
MTC (2 species): IS6110, MPB64
NTM (6 species): 16S rRNA
RegistrationKFDA, CE-IVDCE-IVDCE-IVD
Detection technologyReal-Time PCR
Specimen typeNasopharyngeal swab, Nasopharyngeal aspirate, Bronchoalveolar lavage (BAL)
Analytical sensitivity10 copies
Compatible instruments*ABI 7500 / 7500 Fast Real-Time PCR System (Applied Biosystems)
CFX96™ Real-Time PCR System (Bio-Rad)
PCR running time~ 1 hr 20 min




Features

- HotStart PCR system : Ultra high specific and sensitive result

- DnaFree™ system : No host genomic DNA contamination ( DiaPlexC ™)

- UDG system : No carryover contamination

- Multiplex PCR system : Multiple targets in a single reaction

- Reliable system : Automatic PCR control

- Positive control included

- DNA extraction solution included (Cat. No. SQD21-K100)

- Easy-to-use master mix

- CE certification





Experimental




Sample typeFAMHEXCy5Result
Positive Control+++Valid
Negative Control--+Valid
NTC(Non-Template Control)--+Valid
Sample case 1+++/-MTC, NTM (Co-infection)
Sample case 2+-+/-MTC
Sample case 3-++/-NTM
Sample case 4--+Negative
Sample case 5---Required   re-experiment



Citation&Papers

Korean J Clin microbial, Seong Deok Lee, Hye Young Lee, Hyun Chul Kim, Soo Young Kim,

Mycobacterium tuberculosis and Non-Tuberculous Mycobacteria by PCR Assay.

Ryan KJ, Ray CG (Editors) (2004).

Sherris Medical Microbiology (4th ed.). McGraw-Hill. Clinical Characteristics of Non-Tuberculous Mycobacterial Pulmonary Disease in a National Tuberculosis Hospital.

Sun-Pil Choi, M.D., Bong-Keun Lee M.D.1, Jin-Hong Min, M.D., Jin-Hee Kim, M.D.

Pathogenic Classification and Clinical Charateristics of Non-Tuberculous Mycobacterial Pulmonary Disease in a National Tuberculosis Hospital.





Ordering information

TechnologyCat. No.Product
Real-time PCRSQD21-K100DiaPlexQ™ MTC/NTM Detection Kit (w/Ext.)
SQD20-K100DiaPlexQ™ MTC/NTM Detection Kit
SQD26-K100DiaPlexQ™ MTC/NTM Detection Kit (w/Ext.)- Ver.3.0
SQD25-K100DiaPlexQ™ MTC/NTM Detection Kit- Ver.3.0
SQD28-K100DiaPlexQ™ MTC/NTM Detection Kit (w/Ext.)- Ver.4.0
SQD27-K100DiaPlexQ™ MTC/NTM Detection Kit- Ver.4.0



More products
SOLGENT
DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
For the past 19 years, SolGent grown as a company specialized in human molecular diagnostics projects. In celebration of its 20th anniversary, the company announced its vision of a new start, “SolGent 2.0” and is growing as a bio leader in the 4th Industrial Revolution. Sturdily amassed genome analysis technology and molecular diagnostic technology have become the prominent foundation of the molecular diagnostic market, and SolGent supply products and services with the highest quality to more than 25 countries including domestic research institutes, examination centers, medical institutions and universities. In particular, as “precision medicine,” which analyzes genomes to prevent and predict diseases, becomes a new medical paradigm, SolGent develops and supplies various genome analysis services including for cancer, and expands and applies these services to agricultural products to build the AG-BIO platform. Based on its innovative technology, SolGent develops NADPH coenzyme fixed quantity measurement products DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
Inquiry